Hunan Jiudian Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000034Z6
CNY
16.08
0.24 (1.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,897.44
2,658.30
2,299.64
1,606.62
963.90
912.48
791.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,897.44
2,658.30
2,299.64
1,606.62
963.90
912.48
791.17
Raw Material Cost
818.57
644.44
545.35
370.74
269.26
321.00
335.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.74
11.14
18.52
16.13
5.38
4.75
1.40
Selling and Distribution Expenses
1,312.80
1,400.73
1,288.04
873.45
539.50
439.08
329.84
Other Expenses
20.78
22.63
16.42
11.96
6.43
9.26
5.03
Total Expenditure (Excl Depreciation)
2,357.90
2,282.57
2,016.11
1,379.92
878.47
857.44
717.13
Operating Profit (PBDIT) excl Other Income
539.5
375.7
283.5
226.70000000000002
85.39999999999999
55
74
Other Income
50.66
44.14
32.04
33.08
19.01
12.86
7.75
Operating Profit (PBDIT)
688.15
485.76
369.61
297.64
145.26
101.49
103.96
Interest
18.74
11.14
18.52
16.13
5.38
4.75
1.40
Exceptional Items
0.00
0.00
-0.39
-0.88
0.00
0.00
-0.51
Gross Profit (PBDT)
2,078.87
2,013.86
1,754.29
1,235.89
694.64
591.49
455.63
Depreciation
96.63
72.46
60.48
54.44
49.04
37.85
22.64
Profit Before Tax
572.77
402.16
290.22
226.19
90.84
58.90
79.41
Tax
59.82
33.90
20.52
21.94
8.58
3.83
7.42
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
512.38
368.26
269.70
204.25
82.26
55.07
71.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
512.38
368.26
269.70
204.25
82.26
55.07
71.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
512.38
368.26
269.70
204.25
82.26
55.07
71.99
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,526.73
1,973.27
1,552.62
1,030.03
835.68
761.87
717.84
Earnings per share (EPS)
1.04
0.76
1.4
0.44
0.18
0.12
0.16
Diluted Earnings per share
1.04
0.76
1.4
0.44
0.18
0.12
0.16
Operating Profit Margin (Excl OI)
18.67%
13.89%
12.05%
13.08%
8.01%
5.57%
9.3%
Gross Profit Margin
23.1%
17.85%
15.25%
17.47%
14.51%
10.6%
12.9%
PAT Margin
17.68%
13.85%
11.73%
12.71%
8.53%
6.03%
9.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 8.99% vs 15.60% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 39.13% vs 36.56% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 44.36% vs 30.81% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 68.47% vs -40.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Hunan Jiudian Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,897.44
0
2,897.44
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,897.44
0
2,897.44
Raw Material Cost
818.57
0
818.57
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.74
0
18.74
Selling and Distribution Expenses
1,312.80
0
1,312.80
Other Expenses
20.78
0.00
20.78
Total Expenditure (Excl Depreciation)
2,357.90
0
2,357.90
Operating Profit (PBDIT) excl Other Income
539.53
0.00
539.53
Other Income
50.66
0
50.66
Operating Profit (PBDIT)
688.15
0
688.15
Interest
18.74
0
18.74
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2,078.87
0
2,078.87
Depreciation
96.63
0
96.63
Profit Before Tax
572.77
0
572.77
Tax
59.82
0
59.82
Provisions and contingencies
0
0
0.00
Profit After Tax
512.38
0
512.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
512.38
0
512.38
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
512.38
0
512.38
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,526.73
0
2,526.73
Earnings per share (EPS)
1.04
0
1.04
Diluted Earnings per share
1.04
0
1.04
Operating Profit Margin (Excl OI)
18.67%
0%
0.00
18.67%
Gross Profit Margin
23.10%
0%
0.00
23.10%
PAT Margin
17.68%
0%
0.00
17.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 289.74 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.99% vs 15.60% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 51.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 39.13% vs 36.56% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 44.36% vs 30.81% in Dec 2023

Annual - Interest
Interest 1.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 68.47% vs -40.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.67%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023